Please use this identifier to cite or link to this item:
https://hdl.handle.net/1/1610
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Louie-Johnsun, Mark | en |
dc.contributor.other | Hewitt, P.M. | en |
dc.contributor.other | Perera, D.S. | en |
dc.contributor.other | Morris, D.L. | en |
dc.date.accessioned | 2019-08-29T02:01:23Z | en |
dc.date.available | 2019-08-29T02:01:23Z | en |
dc.date.issued | 2003 | en |
dc.identifier.citation | Volume 5, Issue 3, pp. 191 - 193 | en |
dc.identifier.issn | 1365-182x | en |
dc.identifier.uri | https://elibrary.cclhd.health.nsw.gov.au/cclhdjspui/handle/1/1610 | en |
dc.description.abstract | BACKGROUND: Hepatocellular carcinoma (HCC) is rare in pregnancy but can enlarge rapidly under these circumstances. CASE OUTLINE: A 25-year-old woman was diagnosed with HCC of fibrolamellar type immediately post-partum. One year after liver resection the patient remains well. DISCUSSION: This is only the second report of fibrolamellar carcinoma occurring in pregnancy. Other types of hepatocellular carcinoma in pregnancy have generally demonstrated a poor outcome, probably secondary to hormonal changes and increased liver vascularity. | en |
dc.subject | Cancer | en |
dc.subject | Pregnancy | en |
dc.title | Fibrolamellar hepatocellular carcinoma in pregnancy | en |
dc.type | Journal Article | en |
dc.identifier.doi | 10.1080/13651820310015310 | en |
dc.description.pubmeduri | https://www.ncbi.nlm.nih.gov/pubmed/18332985 | en |
dc.identifier.journaltitle | HPB | en |
dc.relation.orcid | https://orcid.org/0000-0002-7645-2543 | en |
dc.originaltype | Text | en |
item.cerifentitytype | Publications | - |
item.openairetype | Journal Article | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
Appears in Collections: | Oncology / Cancer |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.